The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits

• Sarajo Kumar Mohanta,
• Christian Weber,
• Changjun Yin,
• Andreas J. R. Habenicht

Affiliations

Sarajo Kumar Mohanta

Institute of Cardiovascular Prevention Ludwig‐Maximilians‐University (LMU) Munich Munich Germany

Christian Weber

Institute of Cardiovascular Prevention Ludwig‐Maximilians‐University (LMU) Munich Munich Germany

Changjun Yin

Institute of Precision Medicine The First Affiliated Hospital of Sun‐Yat‐sen University Guangzhou Guangdong China

Andreas J. R. Habenicht

Institute of Cardiovascular Prevention Ludwig‐Maximilians‐University (LMU) Munich Munich Germany